Tarsus Pharmaceuticals, Inc. · 15 hours ago
Intern, Clinical Data Management and Biostatistics
Irvine, California, United States
Internship
Hybrid
Intern
$26/hr - $45/hrTarsus Pharmaceuticals is seeking an intern for their Clinical Data Management and Biostatistics team. This internship offers hands-on experience in the clinical data lifecycle, where interns will work with experienced teams to manage and analyze clinical trial data using industry-leading tools.
BiopharmaBiotechnologyLife Science
Responsibilities
Gain hands-on experience in clinical data management, reviewing clinical trial data in Veeva EDC and tracking issues in CDB
Perform data checks, listing reviews, and reconcile external data to identify trends, inconsistencies, and outliers
Support biostatistics activities by reviewing tables, listings, and figures, and exploring data for insights
Work with industry-leading tools and systems, including Veeva EDC, CDB, JReview, Microsoft Excel, SAS or R, and gain introductory exposure to CDISC standards (SDTM/ADaM)
Work closely with the Clinical Development and Clinical Operations teams through active participation in data review meetings, and project discussions
Build practical, real-world skills that prepare you for a career in Clinical Data Management or Biostatistics
Qualification
Required
Current enrolment in an undergraduate or graduate program majoring in Biostatistics, Statistics, Data Science, Epidemiology, Public Health, or a related field
Strong attention to detail and interest in clinical data quality
Basic understanding of statistics and data analysis concepts
Proficiency in Microsoft Excel
Strong organizational, written, and verbal communication skills
Ability to work independently and collaboratively in a team environment
Familiarity with clinical research, healthcare data, and Good Clinical Practice (GCP)
Preferred
Prior exposure to Veeva EDC, JReview, or clinical data review tools
Basic knowledge of CDISC standards (SDTM/ADaM)
Benefits
Snacks and drinks
Occasional catered meals
Lunch and learns
Development opportunities
Offsite volunteering
Company-wide social events
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Founded in 2017
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bobak Azamian
Chairman
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase